Nu Skin's 10-K Details Variable Rate Debt and Payment Schedule

Ticker: NUS · Form: 10-K · Filed: 2024-02-15T00:00:00.000Z

Sentiment: mixed

Topics: debt, 10-K filing, financials

TL;DR

**Nu Skin's 10-K reveals a 7.46% variable debt rate and 21% of principal due in increasing quarterly installments over five years, starting Sept 2022.**

AI Summary

NU SKIN ENTERPRISES, INC. filed its 10-K on February 15, 2024, for the fiscal year ending December 31, 2023. The filing details debt obligations, including a variable 30-day interest rate of 7.46%. Additionally, 21% of a principal amount is subject to increasing quarterly installments over a five-year period, which commenced on September 30, 2022.

Why It Matters

Understanding Nu Skin's debt structure, including variable interest rates and increasing payment schedules, is crucial for investors to assess the company's financial health and future cash flow obligations.

Risk Assessment

Risk Level: medium — The presence of variable interest rate debt at 7.46% and increasing quarterly principal installments introduces interest rate risk and potential cash flow pressure.

Key Numbers

Key Players & Entities

FAQ

What is the name of the company that filed this 10-K?

The company that filed this 10-K is NU SKIN ENTERPRISES, INC.

What is the fiscal year end reported in this filing?

The fiscal year end reported is December 31, 2023.

What is the variable 30-day interest rate mentioned in the filing?

The variable 30-day interest rate mentioned is 7.46%.

What percentage of the principal amount is payable in increasing quarterly installments?

21% of the principal amount is payable in increasing quarterly installments.

When did the five-year period for these principal installments begin?

The five-year period for these principal installments began on September 30, 2022.

From the Filing

0001140361-24-008111.txt : 20240215 0001140361-24-008111.hdr.sgml : 20240215 20240214215221 ACCESSION NUMBER: 0001140361-24-008111 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 133 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240215 DATE AS OF CHANGE: 20240214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NU SKIN ENTERPRISES, INC. CENTRAL INDEX KEY: 0001021561 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 870565309 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12421 FILM NUMBER: 24641855 BUSINESS ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 BUSINESS PHONE: 801-345-1000 MAIL ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ENTERPRISES INC DATE OF NAME CHANGE: 19980909 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ASIA PACIFIC INC DATE OF NAME CHANGE: 19960919 10-K 1 ef20015265_10k.htm 10-K false 12-31 2023 FY 0001021561 http://fasb.org/us-gaap/2023#UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#RestructuringCostsAndAssetImpairmentCharges http://fasb.org/us-gaap/2023#RestructuringCostsAndAssetImpairmentCharges http://fasb.org/us-gaap/2023#RestructuringCostsAndAssetImpairmentCharges Variable 30 day: 7.46% Variable 30 day: 7.46% 21% of the principal amount is payable in increasing quarterly installments over a five-year period that began on September 30, 2022, with the remainder payable at the end P7Y 238 2024-12-31 2033-12-31 2028-12-31 2031-12-31 2036-12-31 2042-12-31 0001021561 2023-01-01 2023-12-31 0001021561 2023-06-30 0001021561 2024-01-31 0001021561 2023-12-31 0001021561 2022-12-31 0001021561 2022-01-01 2022-12-31 0001021561 2021-01-01 2021-12-31 0001021561 2020-12-31 0001021561 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001021561 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-12-31 0001021561 us-gaap:RetainedEarningsMember 2020-12-31 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001021561 us-gaap:TreasuryStockCommonMember 2020-12-31 0001021561 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001021561 us-gaap:TreasuryStockCommonMember 2021-01-01 2021-12-31 0001021561 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-12-31 0001021561 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001021561 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001021561 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-12-31 0001021561 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001021561 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001021561 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001021561 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001021561 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001021561 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001021561 us-gaap:TreasuryStockCommonMember 2022-12-31 0001021561 us-gaap:RetainedEarningsMember 2021-12-31 0001021561 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001021561 us-gaap:C

View on Read The Filing